Apotex Health Corp. AOTXF
OTC PK
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -27.70M | 262.15M | |||
| Total Depreciation and Amortization | 27.20M | 20.18M | |||
| Total Amortization of Deferred Charges | 1.83M | 2.25M | |||
| Total Other Non-Cash Items | 130.27M | 53.90M | |||
| Change in Net Operating Assets | -110.43M | -44.60M | |||
| Cash from Operations | 21.17M | 293.88M | |||
| Capital Expenditure | -27.52M | -14.27M | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -17.04M | -10.49M | |||
| Cash from Investing | -44.56M | -24.76M | |||
| Total Debt Issued | 274.70M | -- | |||
| Total Debt Repaid | -840.07M | -55.44M | |||
| Issuance of Common Stock | 850.00M | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -53.64M | -- | |||
| Cash from Financing | 166.88M | -40.07M | |||
| Foreign Exchange rate Adjustments | 2.28M | -3.44M | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 145.77M | 225.60M | |||